| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.05▲ | 1.06▼ | 1.07▼ | 1.10▼ | 1.25▼ |
| MA10 | 1.06▲ | 1.07▼ | 1.07▼ | 1.14▼ | 1.34▼ |
| MA20 | 1.07▼ | 1.09▼ | 1.11▼ | 1.25▼ | 1.43▼ |
| MA50 | 1.10▼ | 1.10▼ | 1.13▼ | 1.37▼ | 1.84▼ |
| MA100 | 1.10▼ | 1.18▼ | 1.24▼ | 1.44▼ | 3.05▼ |
| MA200 | 1.16▼ | 1.28▼ | 1.32▼ | 1.79▼ | 8.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.003▼ | -0.003▼ | -0.018▼ | -0.017▼ |
| RSI | 41.994▼ | 38.254▼ | 37.460▼ | 32.914▼ | 35.553▼ |
| STOCH | 32.143 | 44.045 | 21.925 | 20.591 | 23.607 |
| WILL %R | -72.727 | -72.727 | -86.364▼ | -89.744▼ | -94.074▼ |
| CCI | -32.003 | -78.912 | -84.625 | -100.416▼ | -206.892▼ |
| CDL | $SNGX Doji Candlestick Pattern Detected | Set Alert |
|
Thursday, February 12, 2026 04:54 AM
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
|
|
Tuesday, February 03, 2026 07:00 PM
CTCL is a rare form of non-Hodgkin lymphoma that primarily affects the skin, most commonly presenting as mycosis fungoides and Sézary syndrome. It is classified as a chronic, often indolent malignancy ...
|
|
Friday, January 30, 2026 04:58 PM
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/02/26 | 1.10 | 1.10 | 1.045 | 1.06 | 85,453 |
| 11/02/26 | 1.12 | 1.12 | 1.06 | 1.08 | 241,400 |
| 10/02/26 | 1.12 | 1.156 | 1.12 | 1.12 | 44,978 |
| 09/02/26 | 1.14 | 1.18 | 1.12 | 1.12 | 114,400 |
| 06/02/26 | 1.05 | 1.16 | 1.045 | 1.13 | 146,863 |
| 05/02/26 | 1.1635 | 1.1635 | 1.02 | 1.04 | 305,541 |
| 04/02/26 | 1.24 | 1.25 | 1.15 | 1.16 | 218,900 |
| 03/02/26 | 1.24 | 1.2499 | 1.205 | 1.23 | 170,054 |
| 02/02/26 | 1.26 | 1.27 | 1.22 | 1.23 | 123,626 |
| 30/01/26 | 1.31 | 1.32 | 1.23 | 1.25 | 265,200 |
|
|
||||
|
|
||||
|
|